发布求助
文献互助 智能选刊 最新文献

Im Fokus Onkologie最新文献

筛选
英文 中文
Sequenzielle CAR-T-Zell-Therapie: Doppelt hält besser 序贯 CAR T 细胞疗法：安全总比遗憾好
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3767-8
B. Schalhorn
{"title":"Sequenzielle CAR-T-Zell-Therapie: Doppelt hält besser","authors":"B. Schalhorn","doi":"10.1007/s15015-024-3767-8","DOIUrl":"https://doi.org/10.1007/s15015-024-3767-8","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140764290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hautkrebsgefahr Solarium - verschleiert und verkannt 日光浴浴床引发皮肤癌的风险--被隐瞒和误判
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3786-5
G. Nettekoven
{"title":"Hautkrebsgefahr Solarium - verschleiert und verkannt","authors":"G. Nettekoven","doi":"10.1007/s15015-024-3786-5","DOIUrl":"https://doi.org/10.1007/s15015-024-3786-5","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140777998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brustkrebs: Das Immunsystem verändert sich unter der Therapie 乳腺癌：治疗过程中免疫系统的变化
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3791-8
Marie-Thérèse Weitzl
{"title":"Brustkrebs: Das Immunsystem verändert sich unter der Therapie","authors":"Marie-Thérèse Weitzl","doi":"10.1007/s15015-024-3791-8","DOIUrl":"https://doi.org/10.1007/s15015-024-3791-8","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140769628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Die Krux mit der intratumoralen genetischen Heterogenität 肿瘤内遗传异质性的症结所在
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3810-9
Lamia Özgör
{"title":"Die Krux mit der intratumoralen genetischen Heterogenität","authors":"Lamia Özgör","doi":"10.1007/s15015-024-3810-9","DOIUrl":"https://doi.org/10.1007/s15015-024-3810-9","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140771151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nasopharynxkarzinom: EBV-DNA-Titer als Prognosefaktor? 鼻咽癌：作为预后因素的 EBV DNA 滴度？
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3782-9
N. Zink
{"title":"Nasopharynxkarzinom: EBV-DNA-Titer als Prognosefaktor?","authors":"N. Zink","doi":"10.1007/s15015-024-3782-9","DOIUrl":"https://doi.org/10.1007/s15015-024-3782-9","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140779121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Früherkennung von Kopf-Hals-Tumoren: 20 Sekunden reichen aus 早期发现头颈部肿瘤：20 秒就足够了
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3803-8
M. Weiss
{"title":"Früherkennung von Kopf-Hals-Tumoren: 20 Sekunden reichen aus","authors":"M. Weiss","doi":"10.1007/s15015-024-3803-8","DOIUrl":"https://doi.org/10.1007/s15015-024-3803-8","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140794123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MM: Hohe MRD-Negativitätsrate unter Isatuximab-KRd vor und nach ASCT MM：ASCT前后伊沙妥昔单抗-KRd的MRD阴性率高
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3788-3
Birgit-Kristin Pohlmann
{"title":"MM: Hohe MRD-Negativitätsrate unter Isatuximab-KRd vor und nach ASCT","authors":"Birgit-Kristin Pohlmann","doi":"10.1007/s15015-024-3788-3","DOIUrl":"https://doi.org/10.1007/s15015-024-3788-3","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140761345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RCC: Everolimus für die adjuvante Therapie? RCC：辅助治疗用依维莫司？
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3756-y
Sabrina Kempe
{"title":"RCC: Everolimus für die adjuvante Therapie?","authors":"Sabrina Kempe","doi":"10.1007/s15015-024-3756-y","DOIUrl":"https://doi.org/10.1007/s15015-024-3756-y","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140758615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapiealgorithmen beim Ovarial-, Zervix- und Endometriumkarzinom 卵巢癌、宫颈癌和子宫内膜癌的治疗算法
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3785-6
K. Strasser-Weippl, Lea Korber
{"title":"Therapiealgorithmen beim Ovarial-, Zervix- und Endometriumkarzinom","authors":"K. Strasser-Weippl, Lea Korber","doi":"10.1007/s15015-024-3785-6","DOIUrl":"https://doi.org/10.1007/s15015-024-3785-6","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140776272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prähabilitation auf dem Prüfstand 试验台上的预康复
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3796-3
Miriam Sonnet
{"title":"Prähabilitation auf dem Prüfstand","authors":"Miriam Sonnet","doi":"10.1007/s15015-024-3796-3","DOIUrl":"https://doi.org/10.1007/s15015-024-3796-3","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140784034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信